Literature DB >> 24721821

Medial temporal atrophy in early and late-onset Alzheimer's disease.

Enrica Cavedo1, Michela Pievani2, Marina Boccardi2, Samantha Galluzzi2, Martina Bocchetta3, Matteo Bonetti4, Paul M Thompson5, Giovanni B Frisoni6.   

Abstract

Late-onset and early-onset Alzheimer's disease (LOAD, EOAD) affect different neural systems and may be separate nosographic entities. The most striking differences are in the medial temporal lobe, severely affected in LOAD and relatively spared in EOAD. We assessed amygdalar morphology and volume in 18 LOAD and 18 EOAD patients and 36 aged-matched controls and explored their relationship with the hippocampal volume. Three-dimensional amygdalar shape was reconstructed with the radial atrophy mapping technique, hippocampal volume was measured using a manual method. Atrophy was greater in LOAD than EOAD: 25% versus 17% in the amygdala and 20% versus 13% in the hippocampus. In the amygdala, LOAD showed significantly greater tissue loss than EOAD in the right dorsal central, lateral, and basolateral nuclei (20%-30% loss, p < 0.03), all known to be connected to limbic regions. In LOAD but not EOAD, greater hippocampal atrophy was associated with amygdalar atrophy in the left dorsal central and medial nuclei (r = 0.6, p < 0.05) also part of the limbic system. These findings support the notion that limbic involvement is a prominent feature of LOAD but not EOAD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AD; Age at onset; Amygdala; Hippocampus; MRI; Morphology

Mesh:

Year:  2014        PMID: 24721821      PMCID: PMC4053814          DOI: 10.1016/j.neurobiolaging.2014.03.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  69 in total

1.  Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Authors:  David A Wolk; Bradford C Dickerson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

2.  Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.

Authors:  Lieke L Smits; Yolande A L Pijnenburg; Esther L G E Koedam; Annelies E van der Vlies; Ilona E W Reuling; Teddy Koene; Charlotte E Teunissen; Philip Scheltens; Wiesje M van der Flier
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Hippocampal and amygdalar volume changes in elderly patients with Alzheimer's disease and schizophrenia.

Authors:  Annapaola Prestia; Marina Boccardi; Samantha Galluzzi; Enrica Cavedo; Andrea Adorni; Andrea Soricelli; Matteo Bonetti; Cristina Geroldi; Panteleimon Giannakopoulos; Paul Thompson; Giovanni Frisoni
Journal:  Psychiatry Res       Date:  2011-04-01       Impact factor: 3.222

4.  The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.

Authors:  T Gómez-Isla; W B Growdon; M J McNamara; D Nochlin; T D Bird; J C Arango; F Lopera; K S Kosik; P L Lantos; N J Cairns; B T Hyman
Journal:  Brain       Date:  1999-09       Impact factor: 13.501

5.  The topography of grey matter involvement in early and late onset Alzheimer's disease.

Authors:  Giovanni B Frisoni; Michela Pievani; Cristina Testa; Francesca Sabattoli; Lorena Bresciani; Matteo Bonetti; Alberto Beltramello; Kiralee M Hayashi; Arthur W Toga; Paul M Thompson
Journal:  Brain       Date:  2007-02-09       Impact factor: 13.501

Review 6.  The effect of white matter lesions on cognition in the elderly--small but detectable.

Authors:  Giovanni B Frisoni; Samantha Galluzzi; Leonardo Pantoni; Massimo Filippi
Journal:  Nat Clin Pract Neurol       Date:  2007-11

7.  Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.

Authors:  P V Arriagada; K Marzloff; B T Hyman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

8.  Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset alzheimer's disease.

Authors:  Annelies E van der Vlies; Salka S Staekenborg; Faiza Admiraal-Behloul; Niels D Prins; Frederik Barkhof; Hugo Vrenken; Johan H C Reiber; Philip Scheltens; Wiesje M van der Flier
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease.

Authors:  Christiane Möller; Hugo Vrenken; Lize Jiskoot; Adriaan Versteeg; Frederik Barkhof; Philip Scheltens; Wiesje M van der Flier
Journal:  Neurobiol Aging       Date:  2013-04-03       Impact factor: 4.673

10.  Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease.

Authors:  Michael Basso; John Yang; Lauren Warren; Martha G MacAvoy; Pradeep Varma; Richard A Bronen; Christopher H van Dyck
Journal:  Psychiatry Res       Date:  2006-03-09       Impact factor: 3.222

View more
  28 in total

1.  Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.

Authors:  Michio Takahashi; Yasunori Oda; Toshiyuki Okubo; Yukihiko Shirayama
Journal:  J Neural Transm (Vienna)       Date:  2017-05-16       Impact factor: 3.575

2.  Your algorithm might think the hippocampus grows in Alzheimer's disease: Caveats of longitudinal automated hippocampal volumetry.

Authors:  Tejas Sankar; Min Tae M Park; Tasha Jawa; Raihaan Patel; Nikhil Bhagwat; Aristotle N Voineskos; Andres M Lozano; M Mallar Chakravarty
Journal:  Hum Brain Mapp       Date:  2017-03-15       Impact factor: 5.038

3.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2016-03-08       Impact factor: 13.501

4.  Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice.

Authors:  Jing Xiong; Isaac Deng; Sally Kelliny; Liying Lin; Larisa Bobrovskaya; Xin-Fu Zhou
Journal:  Metab Brain Dis       Date:  2022-06-15       Impact factor: 3.655

5.  Early-Stage MRI Volumetric Differences in White Matter Hyperintensity and Temporal Lobe Volumes between Autopsy-Confirmed Alzheimer's Disease, Cerebral Small Vessel Disease, and Mixed Pathologies.

Authors:  Dixon Yang; Arjun Masurkar
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2022-04-26

6.  Shape and diffusion tensor imaging based integrative analysis of the hippocampus and the amygdala in Alzheimer's disease.

Authors:  Xiaoying Tang; Yuanyuan Qin; Jiong Wu; Min Zhang; Wenzhen Zhu; Michael I Miller
Journal:  Magn Reson Imaging       Date:  2016-05-20       Impact factor: 2.546

Review 7.  The basolateral amygdala γ-aminobutyric acidergic system in health and disease.

Authors:  Eric M Prager; Hadley C Bergstrom; Gary H Wynn; Maria F M Braga
Journal:  J Neurosci Res       Date:  2015-11-19       Impact factor: 4.164

8.  Cross-sectional and longitudinal medial temporal lobe subregional atrophy patterns in semantic variant primary progressive aphasia.

Authors:  Laura E M Wisse; Molly B Ungrady; Ranjit Ittyerah; Sydney A Lim; Paul A Yushkevich; David A Wolk; David J Irwin; Sandhitsu R Das; Murray Grossman
Journal:  Neurobiol Aging       Date:  2020-11-23       Impact factor: 4.673

9.  Impact of SORL1 genetic variations on MRI markers in non-demented elders.

Authors:  Rui-Hua Yin; Jun Li; Lin Tan; Hui-Fu Wang; Meng-Shan Tan; Wan-Jiang Yu; Chen-Chen Tan; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2016-05-31

10.  Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.

Authors:  Pierre Eustache; Federico Nemmi; Laure Saint-Aubert; Jeremie Pariente; Patrice Péran
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.